Impact of Alpha-Radiotherapy on the Tumor Microenvironment
- 1 October 2025
- book chapter
- Published by Springer Nature
- p. 637-659
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- First patient exceeding 5-year complete remission after 225Ac-PSMA-TATEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experienceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617European Journal of Nuclear Medicine and Molecular Imaging, 2019
- Mechanisms of PARP inhibitor sensitivity and resistanceDNA Repair, 2018
- 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma modelEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Current Standards of Chemotherapy for Pancreatic CancerClinical Therapeutics, 2017
- 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experienceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- A comparison of brachytherapy techniques for partial breast irradiationBrachytherapy, 2012
- Current controversies in high‐dose‐rate versus low‐dose‐rate brachytherapy for cervical cancerCancer, 2006